FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

MEDRAD OMNIPLANE 300 SYSTEM

K Number: K883834 · Decision Nov 4, 1988
Classifications
1
FEI Numbers
81
Registration Numbers
81
Same Product Code
355
Applicant Total
105
Review Days
56

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
MEDRAD OMNIPLANE 300 SYSTEM
K Number
K883834
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
892.1680
Medical Specialty
Radiology
Decision
Substantially Equivalent
Applicant
Medrad, Inc.
Date Received
September 9, 1988
Decision Date
November 4, 1988
Product Code
KPR
Advisory Committee
Radiology
Review Advisory Committee
RA
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
KPR System, X-Ray, Stationary

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (KPR), ordered by most recent decision date.

View all

Other Clearances by Medrad, Inc.

K Number Device Name
K133023 JETSTREAM XC 2.4/3.4; JETSTREAM XC 2.1/3.0; JETSTREAM SC 1.85; JETSTREAM SC 1.6
K130381 ANGIOJET ULTRA POWER PULSE KIT
K130637 JETSTREAM XC 2.4/3.4 SYSTEM; JETSTREAM XC 2.1/3.0 SYSTEM; JETSTREAM SC 1.85 SYSTEM; JETSTREAM SC 1.6 SYSTEM
K122916 JETSTREAM NAVITUS L SYSTEM JEYSTREAM NAVITUS SYSTEM JETSTREAM G3 SF SYSTEM JETSTREAM SF 1.6 SYSTEM
K113363 ANGIOJET SOLENT DISTA THROMBECTOMY SET
K113133 MEDRAD MARK 7 ARTERION (PEDESTAL SYSTEM), (TABLE MOUNT SYSTEM), MEDRAD MARK 7 ARTERION ARTERION SYRINGE
K113428 ANGIOJET ULTRA DVX THROMBECTOMY SET
K112086 MEDRAD MARK 7 ARTERION (PEDESTAL SYSTEM / TABLE MOUNT SYSTEM), MEDRAD MARK 7 ARTERION SYRINGE
K111182 ANGIOJET SOLENT OMNI THROMBECTOMY SET
K100798 MEDRAD INTEGO PET INFUSION SYSTEM, SOURCE ADMINISTRATION SET, PATIENT ADMINSTRATIN SET MODEL INT SYS 100, INT CSS, INT C
Search all 105 clearances from Medrad, Inc. →